Benzinga | Jul 17, 2020 07:36AM EDT

Foresight To Initiate Pilot Project For Its COVID-19 Symptom Detection Solution

One of Israel's largest health maintenance organizations (HMO), Meuhedet, will use the system to screen up to 50,000 of its patients in the city of Ashdod

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision, announced today that it will begin a pilot project for its prototype COVID-19 symptom detection mass screening solution. The technology will be evaluated for several months by Meuhedet, one of Israel's largest health maintenance organizations.

Meuhedet serves over one million patients from all sectors across Israel and maintains more than 300 clinics throughout the country. The pilot project will be carried out in Meuhedet's largest clinic in Ashdod which serves approximately 50,000 patients. To date, several entire neighborhoods in Ashdod have been quarantined due to a large number of confirmed coronavirus patients.

Foresight's solution, which is based on the Company's extensive knowledge of thermal and visible-light cameras, artificial intelligence and advanced algorithms, is designed to rapidly and accurately detect some of the main symptoms associated with the COVID-19 virus. The combination of several symptoms increases the likelihood of accurate detection and potentially eliminates false positive results.

The system will be installed, with no consideration to the Company, at the entrance to the clinic, and will allow screening of all incoming patients. Initial detection of high body temperature will determine if further testing for fatigue and cough symptoms is required. Real-time data collected by the system will allow Foresight to further develop and improve the system, as more data is collected.

"As the COVID-19 virus continues to spread, it is of great concern to find a solution that will help to detect early symptoms of the coronavirus and offer a solution aimed at preventing another pandemic outbreak. This first pilot project with a leading Israeli HMO validates the need for Foresight's new screening solution in high-traffic areas such as health clinics. Based on the large number of Mehuedet clinics throughout Israel, a successful pilot project may lead to further evaluation and future commercial orders," said Haim Siboni, CEO of Foresight.